Mark Pool
Rush University Medical Center(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, RNA modifications and cancer, Cancer-related Molecular Pathways, RNA Research and Splicing
Most-Cited Works
- → Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro(2007)116 cited
- → Knockdown of splicing factor SRp20 causes apoptosis in ovarian cancer cells and its expression is associated with malignancy of epithelial ovarian cancer(2010)96 cited
- → The serum-based VeriStrat® test is associated with proinflammatory reactants and clinical outcome in non-small cell lung cancer patients(2018)41 cited
- → CDKN2A (p16) Promoter Hypermethylation Influences the Outcome in Young Lung Cancer Patients(2012)32 cited
- → Pyrogen reactions to human serum albumin during plasma exchange(1995)24 cited
- → Biphenotypic sinonasal sarcoma: Report of 3 cases with a review of literature(2021)15 cited
- → PCR Production of a Digoxigenin-labeled Probe for the Detection of Human Cytomegalovirus in Tissue Sections(1994)11 cited
- → Differential expression of circulating biomarkers of tumor phenotype and outcomes in previously treated non-small cell lung cancer patients receiving erlotinib vs. cytotoxic chemotherapy(2017)11 cited
- → Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum(2018)9 cited
- → The association between PTEN expression and survival in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with erlotinib.(2010)3 cited